The Duke CTSA KL2 provides skilled and personalized mentoring, a coordinated and tailored scientific and career development curriculum, and the opportunity to conduct clinical or translational (bench to bedside) research. The KL2 program is particularly committed to increasing diversity of the research workforce. Therefore, we have set a goal that at least 50% of KL2 scholars will be from underrepresented racial and ethnic groups (UREGs). Members of underrepresented groups are encouraged to apply.
Up to three Scholars will be awarded 75% total protected effort for 3 years, up to $20,000/year for research expenses, and up to $2,500/year for travel to professional meetings. Benefits are contingent upon available funding. Funding will start July, 2020. Applications are due November 25, 2019.
Individuals considering applying to the Duke CTSA KL2 are strongly encouraged to submit a Letter of Intent by November 1, 2019 via MyResearchProposal.
If applying to the Duke CTSA KL2, please consider the REACH Equity and KL2 Application Preparation Program (REKAPP). REKAPP is a 6-8 week program in which participants will work with a faculty member and a small peer group on specific parts of the KL2 application. Space is limited.
For more information about the CTSA KL2 and how to apply to the KL2: https://www.ctsi.duke.edu/translational-training-workforce-development/duke-ctsa-kl2
For more information about REKAPP: http://bit.ly/duke-REKAPP
Contact for questions about the program:
Stephanie Molner, MSW, stephanie.Molner@dm.duke.edu
CTSA Education Administrator
Laura Svetkey, MD, MHS, laura.Svetkey@dm.duke.edu
Kimberly Johnson, MD, kimberly.S.Johnson@dm.duke.edu
Rasheed Gbadegesin, MBBS, MD, rasheed.Gbadegesin@duke.edu